Status:

COMPLETED

Calcium and Gut Hormones

Lead Sponsor:

University of Bath

Conditions:

Obesity

Diabetes

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Gut hormones have therapeutic potential in the prevention and treatment obesity and type 2 diabetes (T2D). Rodent evidence suggests that calcium may stimulate gut hormone secretion. Evidence in humans...

Eligibility Criteria

Inclusion

  • Healthy men and women age between 18-65 yrs.
  • Able to consume provided supplement.
  • Weight stable for the past 3 month (no change within 3%)

Exclusion

  • Any previous or current metabolic, cardio-pulmonary or musculoskeletal disease
  • Not between the ages of 18-65 years
  • A body mass index below 18.5 kg/m2 or above 30 kg/m2 (body mass (kg) divided by your height (m) squared)
  • Taking medications that may influence your metabolism
  • Plans to change your lifestyle (diet and/or physical activity) during the study period
  • Not willing to refrain from alcohol containing drinks or unaccustomed exercise one day before the laboratory sessions.
  • Current smoker

Key Trial Info

Start Date :

October 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 28 2018

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT03370484

Start Date

October 1 2017

End Date

February 28 2018

Last Update

August 28 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department for Health, University of Bath

Bath, United Kingdom, BA2 7AY